Everest Group European Life Sciences ITO PEAK Matrix 2014

The surge in European life sciences ITO is being shaped by restructuring efforts, increasing regulatory scrutiny, uptick in infrastructure services, and adoption of analytics. European life sciences buyers are looking at service providers with the relevant domain expertise and solutions across next-generation services. HCL Technologies has demonstrated significant growth in the European life sciences business driven by a focused portfolio of offerings.

Download case study to read more.